|12 Months Ended|
Dec. 31, 2020
|Inventory Disclosure [Abstract]|
|SCHEDULE OF INVENTORY||
At December 31, 2020 and 2019, inventory was comprised of the following:
SCHEDULE OF INVENTORY
The anticipated year-over-year increase of inventory is based on the Company’s implementation of its aforementioned Consolidation Plan whereby it is transitioning from a management and advisory firm in the cannabis space, to a cannabis licensee and direct owner of cannabis cultivation, manufacturing, and dispensary operations.
Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef